您的位置：山东大学 -> 科技期刊社 -> 《山东大学学报（医学版）》

山东大学学报 (医学版) ›› 2021, Vol. 59 ›› Issue (1): 49-54.doi: 10.6040/j.issn.1671-7554.0.2020.1112

• 临床医学 • 上一篇    下一篇

3 514例乳腺癌9年间临床及病理学特征分析

游雪婷1,田兴松1,2   

  1. 1.山东大学附属省立医院乳腺甲状腺外科, 山东 济南 250021;2. 山东第一医科大学附属省立医院乳腺甲状腺外科, 山东 济南 250021
  • 发布日期:2021-01-09
  • 通讯作者: 田兴松. E-mail:txs0509@163.com
  • 基金资助:
    山东省自然科学基金面上项目(ZR2019MH118);济南市科技计划项目(201805011)

Analysis of clinicopathological characteristics of 3 514 cases of breast cancer over 9 years

YOU Xueting1, TIAN Xingsong1,2   

  1. 1. Department of Breast and Thyroid Surgery, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan 250021, Shandong, China;
    2. Department of Breast and Thyroid Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250021, Shandong, China
  • Published:2021-01-09

PDF (PC)

319

摘要： 目的 分析3 514例乳腺癌患者9年间的临床病理学特征。 方法 回顾分析2010年7月至2018年6月就诊于山东大学附属省立医院乳腺甲状腺外科并行手术治疗的乳腺癌患者的临床病理资料,信息来源于病例病案记录,采用相对数及构成比描述分析其临床及病理学特征指标。 结果 3 514例乳腺癌患者性别(男/女)比例为1.00∶318.45,中位发病年龄为50岁,发病高峰年龄为40~50岁,最高峰年龄段为45~50岁。同时性双侧乳腺癌占所有乳腺癌患者的1.05%,多灶性/多中心性乳腺癌占所有乳腺癌患者的5.07%。主要病理类型为浸润性导管癌,其次为导管内癌。9年间乳腺癌患者的病理类型构成比差异有统计学意义(P<0.001)。TNM 0期及Ⅰ期乳腺癌患者的年间构成比差异有统计学意义(P=0.004,P=0.009)。组织学Ⅱ级、Ⅱ~Ⅲ级和Ⅲ级的年间构成比差异有统计学意义(P<0.001)。Luminal A型、Luminal B型及HER-2阳性(HR阴性)型的年间构成比差异均有统计学意义(P<0.001,P<0.001,P=0.032)。乳腺癌伴随乳腺增生病9年间构成比的差异有统计学意义(P=0.047)。9年间肿瘤累及脉管的比例的差异有统计学意义(P=0.018)。9年间乳腺癌患者的淋巴结转移情况差异也有统计学意义(P=0.003)。 结论 研究阐明了3 514例乳腺癌患者的发病年龄、性别比例、病理类型、分子分型、分期等临床及病理特征及其于9年间的变化状况,可为山东省乳腺癌患者的临床病理特征研究提供信息。

关键词: 乳腺肿瘤, 病理特征, 临床特征, 单中心, 年间变化

Abstract: Objective To analyze the clinicopathological characteristics of breast cancer. Methods The clinicopathological data of 3 514 patients who underwent surgery in Department of Breast and Thyroid Surgery of Provincial Hospital Affiliated to Shandong University during July 2010 and June 2018 were retrospectively analyzed. All information was obtained from the medical records. The clinicopathological characteristics were described and analyzed using the relative number and constituent ratio. Results The gender ratio(male/female)was 1.00∶318.45, median age of onset was 50, peak age of onset was 40-50, and the highest peak age was 45-50. Synchronous bilateral and multifocal/multicentric breast cancer accounted for 1.05% and 5.07% of all cases, respectively. The main pathological type was invasive ductal carcinoma, followed by intraductal carcinoma. There were significant differences in the constituent ratio of pathological types(P<0.001); interannual constituent ratio of TNM stage 0 and stage Ⅰ(P=0.004, P=0.009); annual constituent ratio of histological grade Ⅱ,Ⅱ-Ⅲ, and Ⅲ(P<0.001); annual constituent ratio of Luminal A, Luminal B and HER-2 positive(HR negative)types(P<0.001, P<0.001, P=0.032); constituent ratio of breast cancer complicated with hyperplasia of mammary glands(P=0.047); proportion of vascular invasion(P=0.018); and lymph node metastasis(P=0.003). Conclusion The clinicopathological characteristics of 3 514 breast cancer patients, including age of onset, gender ratio, pathological types, molecular classifications and stages over 9 years are elucidated, which can provide reference for the study of clinicopathological characteristics of breast cancer patients in Shandong Province.

Key words: Breast cancer, Pathological characteristics, Clinical features, Monocentric, Inter-annual variation

中图分类号: 

  • R737.9
[1] Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6): 394-424.
[2] Leong SP, Shen ZZ, Liu TJ, et al. Is breast cancer the same disease in Asian and Western countries? [J]. World J Surg, 2010, 34(10): 2308-2324.
[3] Fan L, Zheng Y, Yu KD, et al. Breast cancer in a transitional society over 18 years: trends and present status in Shanghai, China [J]. Breast Cancer Res Treat, 2009, 117(2): 409-416.
[4] Fan L, Strasser-Weippl K, Li JJ, et al. Breast cancer in China [J]. Lancet Oncol, 2014, 15(7): e279-e289.
[5] Fan L, Goss PE, Strasser-Weippl K. Current status and future projections of breast cancer in asia [J]. Breast Care(Basel), 2015, 10(6): 372-378.
[6] Kim Z, Min SY, Yoon CS, et al. The Basic Facts of Korean Breast Cancer in 2012: Results from a Nationwide Survey and Breast Cancer Registry Database [J]. J Breast Cancer, 2015, 18(2): 103-111.
[7] Li J, Zhang BN, Fan JH, et al. A nation-wide multicenter 10-year(1999-2008)retrospective clinical epidemiological study of female breast cancer in China [J]. BMC Cancer, 2011, 11: 364.
[8] Shi J, Liang D, Jin J, et al. Female breast cancer burden was increasing during the 40 years in Hebei Province, China: a population-based study [J]. Arch Gynecol Obstet, 2016, 294(5): 1063-1071.
[9] 李全华, 马万里, 姚开颜, 等. 浙江省嘉善县1988~2012年女性乳腺癌发病趋势分析[J].中国肿瘤, 2015, 24(1): 22-26. LI Quanhua, MA Wanli, YAO Kaiyan, et al. An Analysis of Incidence Trend of Female Breast Cancer in Jiashan County, Zhejiang Province,1988~2012 [J]. China Cancer, 2015, 24(1): 22-26.
[10] 王铁霖. 中国西部9868例乳腺癌发病年龄及激素受体状态分析[D]. 重庆: 重庆医科大学, 2018.
[11] 徐英, 雷林, 刘峥, 等. 2001~2015年深圳市女性乳腺癌发病年龄特征分析[J]. 现代预防医学, 2019, 46(13): 2375-2378. XU Ying, LEI Lin, LIU Zheng, et al. Age characteristics of female breast cancer, Shenzhen,2001-2015 [J]. Modern Preventive Medicine, 2019, 46(13): 2375-2378.
[12] Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019 [J]. CA Cancer J Clin, 2019, 69(1): 7-34.
[13] Liu N, Johnson KJ, Ma CX. Male breast cancer: an updated surveillance, epidemiology, and end results data analysis [J]. Clin Breast Cancer, 2018, 18(5): e997-e1002.
[14] Ishii T, Nakano E, Watanabe T, et al. Epidemiology and practice patterns for male breast cancer compared with female breast cancer in Japan [J]. Cancer Med, 2020, 9(16): 6069-6075.
[15] 赵敏, 尹菊芬, 龙飞, 等. 5917例乳腺癌患者疾病构成特征分析[J].中国病案, 2018, 19(3): 63-66. ZHAO Min, YIN Jufen, LONG Fei, et al. Analysis on the disease composition characteristics of 5917 cases of breast cancer patients [J]. Chinese Medical Record, 2018, 19(3): 63-66.
[16] Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015 [J]. CA Cancer J Clin, 2016, 66(2): 115-132.
[17] 李祥, 郑红梅, 何建平, 等. 2012年湖北省乳腺癌发病与死亡情况分析[J]. 肿瘤防治研究, 2018, 45(2): 96-100. LI Xiang, ZHENG Hongmei, HE Jianping, et al. Breast cancer incidence and mortality in hubei province, 2012 [J]. Cancer Research on Prevention and Treatment, 2018, 45(2): 96-100.
[18] Kollias J, Pinder SE, Denley HE, et al. Phenotypic similarities in bilateral breast cancer [J]. Breast Cancer Res Treat, 2004, 85(3): 255-261.
[19] Hartman M, Czene K, Reilly M, et al. Genetic implications of bilateral breast cancer: a population based cohort study [J]. Lancet Oncol, 2005, 6(6): 377-382.
[20] Kheirelseid EA, Jumustafa H, Miller N, et al. Bilateral breast cancer: analysis of incidence, outcome, survival and disease characteristics [J]. Breast Cancer Res Treat, 2011, 126(1): 131-140.
[21] Carmichael AR, Bendall S, Lockerbie L, et al. The long-term outcome of synchronous bilateral breast cancer is worse than metachronous or unilateral tumours [J]. Eur J Surg Oncol, 2002, 28(4): 388-391.
[22] Schmid SM, Pfefferkorn C, Myrick ME, et al. Prognosis of early-stage synchronous bilateral invasive breast cancer [J]. Eur J Surg Oncol, 2011, 37(7): 623-628.
[23] Tot T. The role of large-format histopathology in assessing subgross morphological prognostic parameters: a single institution report of 1000 consecutive breast cancer cases [J]. Int J Breast Cancer, 2012, 2012: 395415. doi: 10.1155/2012/395415.
[24] Lynch SP, Lei X, Chavez-MacGregor M, et al. Multifocality and multicentricity in breast cancer and survival outcomes [J]. Ann Oncol, 2012, 23(12): 3063-3069.
[25] Bendifallah S, Werkoff G, Borie-Moutafoff C, et al. Multiple synchronous(multifocal and multicentric)breast cancer: clinical implications [J]. Surg Oncol, 2010, 19(4): e115-e123.
[26] Salgado R, Aftimos P, Sotiriou C, et al. Evolving paradigms in multifocal breast cancer [J]. Semin Cancer Biol, 2015, 31: 111-118. doi: 10.1016/j.semcancer.2014.07.002.
[27] Houssami N, Ciatto S, Macaskill P, et al. Accuracy and surgical impact of magnetic resonance imaging in breast cancer staging: systematic review and meta-analysis in detection of multifocal and multicentric cancer [J]. J Clin Oncol, 2008, 26(19): 3248-3258.
[28] Katz A, Strom EA, Buchholz TA, et al. The influence of pathologic tumor characteristics on locoregional recurrence rates following mastectomy [J]. Int J Radiat Oncol Biol Phys, 2001, 50(3): 735-742.
[1] 巩雨,高震,王虎清,杨晶雯,张桂莲,展淑琴,张茹,吴海琴. 4例继发性肥大性下橄榄核变性的临床及影像学特点[J]. 山东大学学报 (医学版), 2022, 60(5): 37-42.
[2] 王静,刘粉,曾荣,黄思源,许长娟,梁子婷,董亮. 以胸膜病变为特征的IgG4相关性肺疾病1例[J]. 山东大学学报 (医学版), 2022, 60(3): 114-116.
[3] 穆彦熹,汪文杰,陈康,姚亚龙,李金洲,魏浩旗,刘海鹏,黄泽平,陈晓. 探寻一家系短期3例胃癌的临床病理及其相关肿瘤特征[J]. 山东大学学报 (医学版), 2022, 60(11): 96-101.
[4] 曹爱华,段春红,邱丙平,路苓,李可亮, 刘学工,周志远,孙建华,鞠秀丽. 山东省儿童新型冠状病毒感染者流行病学及临床特征[J]. 山东大学学报 (医学版), 2020, 58(6): 34-40.
[5] 李杨, 王中素, 刘鲁祁, 刘天起, 王东, 柳雪, 王明华, 侯应龙. 某三甲医院80例感染性心内膜炎患者临床特征及内外科疗效比较[J]. 山东大学学报 (医学版), 2020, 58(6): 22-27.
[6] 雷宇,陆婧,顾佳颖,周登峰,李园园,卢桥发. 新型冠状病毒肺炎51例临床特征[J]. 山东大学学报 (医学版), 2020, 58(4): 65-70.
[7] 周生余,王春亭,张伟,王锡明,董亮. 山东省新型冠状病毒肺炎患者537例临床特征与救治效果[J]. 山东大学学报 (医学版), 2020, 58(3): 44-51.
[8] 崔亮亮,耿兴义,赵小冬,杨国樑,常彩云,赵梦娇,李战,王春荣,刘岚铮,阮师漫. 济南市现阶段新型冠状病毒肺炎的流行特征与思考[J]. 山东大学学报 (医学版), 2020, 58(3): 52-57.
[9] 张孝国,马艳,肖嘉安,张忠法. 济南市儿童新型冠状病毒肺炎的临床特征[J]. 山东大学学报 (医学版), 2020, 58(3): 62-64.
[10] 商蒙蒙,张岩,程琳,孙霄,时丹丹,闵香,李杰. 弹性应变率比值法与声触诊组织量化技术对乳腺肿块的诊断价值[J]. 山东大学学报 (医学版), 2019, 57(6): 94-99.
[11] 赵学英,樊明德,董文艳,亓颖芝,芦鑫. 三结构域蛋白26在胶质瘤组织中的表达及临床意义[J]. 山东大学学报 (医学版), 2019, 57(3): 63-68.
[12] 苗萌,贾国勇,刘颖,王翠兰. 36例成人流行性乙型脑炎临床分析和影像学特点[J]. 山东大学学报 (医学版), 2018, 56(2): 23-27.
[13] 李杰,何东,张睿,杨帆,冯少滨,杨依航,辛涛. 核转运蛋白α2在胶质瘤中的表达及对其生物学行为的影响[J]. 山东大学学报 (医学版), 2018, 56(12): 47-54.
[14] 李劳冬,明莫瑜,蒋连强,蒋清柏,凌宙贵,吴昕. 气管血管球瘤1例并文献复习[J]. 山东大学学报 (医学版), 2018, 56(12): 111-113.
[15] 李星凯,刘战业,姜运峰,李军. 原发性中央型和周围型肺鳞癌临床病理学及预后差异[J]. 山东大学学报（医学版）, 2017, 55(9): 73-78.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
[1] 孙维彤,邹伟伟,李爱国,席延伟,张娜. 脂质体粒径对促进托氟啶口服吸收的影响[J]. 山东大学学报(医学版), 2007, 45(6): 639 -642 .
[2] 于清梅,武玉玲,宋海岩,尹华伟,庄园 . p38丝裂原活化蛋白激酶在小鼠早期胚胎及围植入期子宫内膜的表达[J]. 山东大学学报(医学版), 2008, 46(2): 123 -127 .
[3] 张勇,叶静,郭新星,肖水清. 牙周膜牵张成骨快速移动牙牙髓中IL-8表达的变化[J]. 山东大学学报(医学版), 2008, 46(4): 379 -381 .
[4] 肖伟玲,林亚杰,牟东珍,孙萍,梁淑娟 . 分泌型人IL-1β表达载体的构建及在H7402细胞中的表达[J]. 山东大学学报(医学版), 2008, 46(2): 119 -122 .
[5] 杨奎忠,孙雪飞,项继顺,杜庆聪,黄凤昌 . c-FLIP反义寡核苷酸对食管癌EC109细胞裸鼠移植瘤抑制作用的实验研究[J]. 山东大学学报(医学版), 2007, 45(12): 1234 -1238 .
[6] 俞新爽,韩俊庆,王兴文,盛巍,王瑜. 乳腺癌患者细胞免疫水平与预后危险因素的关系及临床意义[J]. 山东大学学报(医学版), 2007, 45(9): 934 -937 .
[7] 李安源,解砚英,李杰,王芃,徐淑兰,赵林 . 一服清颗粒治疗上呼吸道感染的药效学研究[J]. 山东大学学报(医学版), 2007, 45(9): 951 -954 .
[8] 徐宁宇 王磊 郝恩魁 苏国海. STEMI患者急诊PCI前口服阿托伐他汀对炎症介质及左心室功能的影响[J]. 山东大学学报(医学版), 2209, 47(6): 69 -72 .
[9] 王海峰,史本康,张克勤,李永智,朱耀丰,王海新. B超检测的精索静脉直径及返流与术后精液质量的关系[J]. 山东大学学报(医学版), 2007, 45(7): 751 -752 .
[10] 张元凯，刘培来，李德强，李明. 枢椎椎板螺钉联合寰椎侧块螺钉固定技术在复杂寰枢椎脱位中的应用[J]. 山东大学学报(医学版), 2010, 48(11): 98 .
版权所有 © 2018 《山东大学学报(医学版)》编辑部　
地址:山东大学科技期刊社（济南市历城区山大南路27号山东大学中心校区明德楼B座721室） 电话: 0531-88366918 E-mail: xbyxb@sdu.edu.cn
本系统由北京玛格泰克科技发展有限公司设计开发